嘉晨西海(杭州)生物技术有限公司

Immorna Therapeutics (嘉晨西海生物技术有限公司), is a well-funded start-up biotech company that focuses on discovering and developing mRNA-based vaccines and therapeutic drugs for patients with cancers and other life-threatening diseases. We do this by:

Developing drugs against the right targets using the most advanced technologies.

Using a combination of in-house developed technology and informed diligence on the latest research, we develop mRNA-based vaccines and drugs with the most efficient, safest, and cost-saving industry process.

Building products with world-class leadership and R&D personnel.

We were founded by biotech executives with over 30 years of combined experience in world’s top pharmaceutical companies. Our company employs industry-leading talents that work closely with world’s top academic institutions and established pharmaceutical industry to advance a wide variety of drug programs at the highest level of scientific rigor. Our team combines biopharmaceutical veterans with up-and-coming leaders to drive entrepreneurial thinking grounded by experience.